Investors Relations
Invest in Onward Assist: Revolutionizing Digital Pathology
Investors & Enablers
A Unique Opportunity in AI-Driven Healthcare Solutions
Onward Assist stands at the forefront of the rapidly growing digital pathology market, offering innovative AI-powered solutions that address critical needs in cancer diagnostic
Our USP
Addressing a Critical Market Need
- Transforming subjective, time-consuming manual slide reporting
- Enhancing diagnostic accuracy in cancer pathology
- Streamlining digital pathology workflows
Market Differentiation
- Superior products and advanced AI algorithms
- Partnerships with leading cancer institutes and diagnostic networks
- Robust AI tools compatible with high-end scanners and low-cost microscope cameras
- Founded on strong technical (AI) and healthcare domain expertise
AI-Powered Pathology Intelligence
- AI-assisted analysis designed to support digital slide review
- Enables quantitative insights from pathology images
- Supports faster and more consistent pathology workflows
Proven Customer Success
- Commercial deployments at prestigious institutions:
- AIIMS Delhi
- Tata Memorial Center
- PGI Chandigarh
- International collaboration with Roche Africa for telepathology in West Africa
Experienced Leadership Team
- 80+ years of collective experience across the healthcare industry
- Expertise in sales, cancer research, business management, AI, and lab operations
Track Record of Innovation
- Five AI algorithm products in production grade
- Positive feedback from customers
- Demonstrated ability to meet the needs of pathology laboratories and cancer pathologists
Substantial Market Growth Potential
Digital pathology is rapidly transforming healthcare, creating expanding opportunities across diagnostics, telepathology, research, biopharma, and education. Onward Assist is positioned to capitalize on this growth through scalable, AI-enabled digital pathology solutions.
14,000+
Digital Pathology Labs
15%+
Annual Market Growth
$2B+
Digital Pathology Market Opportunity
Why Invest Now?
- Participate in the transformation of cancer care and oncopathology practices
- Gain exposure to cutting-edge AI technology in healthcare
- Tap into the growing digital pathology market in India and globally
- Realize substantial returns on investment
TestimonialsWhat our customers say about us
“Since implementing this telepathology software solution provided by Onward, we have been able to report 99% of our cases remotely. The platform’s remote viewing capabilities and seamless communication with spoke centers have enhanced our telepathology workflow. We’ve reduced our turnaround time from 7-10 days to just 24 hours for providing second opinions on cases from peripheral spoke centers. This efficiency not only accelerates patient care but also supports timely, accurate diagnoses, demonstrating the transformative impact of this technology on our diagnostic processes.”
“We used the Slide Scholar software platform at our Hospital – Homi Bhabha Cancer Hospital and Research Centre (Tata Memorial Center) Mullanpur.
And we are happy with the functioning and features of Slide Scholar platform. We recently used the platform for our conference, in which we had hosted our clinical whole slide images and we were able to organize the slide according to our seminar topics such as Thyroid, Cytopathology, etc. We were then able to share this with our conference participants in a secure manner.
The faculty found it user-friendly to use the platform, the viewer for conduct of their lecture sessions.”
“Slide Scholar is a user friendly, simple and effective tool for classes, conferences and MDTs.”
